CDD for Biologics Summit Boston 2017

Kongressthemen
Biologic-based therapeutics have continued to become more complex both by modality and delivery. Much like the small molecule arena, computational tools are being sought to streamline drug design, development and manufacture.

The 2nd Annual Computational Drug Development (CDD) for Biologics Summit is dedicated to exploring the application of in-silico tools within the development paradigm for biologics.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Speakers: Stanley Krystek (Bristol Myers-Squibb), Chris Roberts (University of Delaware), Vanita Sood (EMD Serono), Sarah Sirin (AbbVie), Bernhardt L Trout (MIT)

URLs: Brochure: https://go.evvnt.com/158061-1 Booking: https://go.evvnt.com/158061-2

Customer Services